Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1.

• PSNCBAM-1 is an allosteric modulator of the cannabinoid receptor 1. • Derivatives of PSNCBAM-1 were made, to reduce the total rings in the structure. • Several derivatives maintained allosteric activity, as shown by binding experiments. • Some calculated physicochemical properties for these deriva...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Therapeutic Research Vol. 92
Autores principales: Dopart, Rachel, Immadi, Sri Sujana, Lu, Dai, Kendall, Debra A.
Formato: research tables/charts Journal Article
Publicado: Elsevier B.V. 2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144690106&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144690106
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0011393X
        KIH
      jtl: Current Therapeutic Research
      issn: 0011393X
      maglogo: N
    pubinfo:
      dt: 2020
      vid: 92
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        144690106
        144690106
        144690106
        10.1016/j.curtheres.2019.100574
        144690106
      ppct: 1
      formats:
      tig:
        atl: Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1.
      aug:
        au:
          Dopart, Rachel
          Immadi, Sri Sujana
          Lu, Dai
          Kendall, Debra A.
        affil: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut
      sug:
        subj:
          Urea Analysis
          Cannabinoids Analysis
          Pyridines Analysis
          Receptors, Cell Surface Analysis
          Urea Antagonists and Inhibitors
          Cannabinoids Antagonists and Inhibitors
          Pyridines Antagonists and Inhibitors
          Receptors, Cell Surface Antagonists and Inhibitors
          Human
          Molecular Structure
          Piperidines Analysis
          Solubility
          Bioinformatics
          Computer Simulation Methods
          Biochemical Phenomena
      ab: • PSNCBAM-1 is an allosteric modulator of the cannabinoid receptor 1. • Derivatives of PSNCBAM-1 were made, to reduce the total rings in the structure. • Several derivatives maintained allosteric activity, as shown by binding experiments. • Some calculated physicochemical properties for these derivatives are provided. Structure–activity relationship studies improve the pharmacological and pharmacokinetic properties of a lead compound such as PSNCBAM-1, an allosteric modulator of the cannabinoid receptor 1. Here, several derivatives of PSNCBAM-1 were synthesized with the aim of reducing the number of rings within its structure and enhancing the solubility of the compounds. The derivatives studied contain substituents previously shown to enhance binding of agonists (ie, a cyano group and a pyrimidine ring), with a reduced number of rings compared with the parent compound, PSNCBAM-1. The synthesized compounds were tested for the enhancement of the binding of orthosteric cannabinoid receptor 1 agonist CP55,940 in the presence of varying concentrations of each test compound. Select compounds were also tested for their effects on cannabinoid receptor 1 inverse agonist SR141716A binding. The compounds were also subjected to computational analysis of drug-like properties and solubility. Consistent with a positive allosteric modulator for orthosteric ligand binding, compounds LDK1317 (12a), LDK1320 (12b), LDK1321 (6a), LDK1323 (8a), and LDK1324 (6b) all enhanced the binding of agonist CP55,940 to some degree. Reduction in the number of rings did not abolish the activity. The new lead compounds LDK1317 (12a) and LDK1321 (6a) showed improved drug-like properties and enhanced solubility in silico. In contrast to PSNCBAM-1, the synthesized compounds are analogs with fewer rings. The compounds LDK1317 (12a) and LDK1321 (6a) contained only 2 or 3 rings, respectively, and showed the binding parameters (K B = 110 nM, α = 2.3, and K B = 85 nM, α = 5.9). Further, the computationally predicted drug-like properties and solubility suggest these compounds are acceptable new lead compounds for further development of cannabinoid receptor 1 allosteric modulators. (Curr Ther Res Clin Exp. 2020; 81:XXX–XXX)
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N